Gene transfer of a novel vasoactive natriuretic peptide stimulates cGMP and lowers blood pressure in mice

Shuchong Pan, Rajiv Gulati, Cheryl S. Mueske, Tyra A. Witt, Amir Lerman, John C Jr. Burnett, Robert D. Simari

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Dendroaspis natriuretic peptide (DNP) is a recently described peptide produced by Dendroaspis angusticeps with structural and functional similarities to mammalian natriuretic peptides. These similarities suggest a potential role for DNP in cardiovascular therapeutics. To determine the physiological effects of chronic delivery of DNP, a gene transfer approach using first generation adenoviral vectors was utilized. Although the gene for DNP has not been cloned in any species, the peptide sequence in the snake is known. Preferred mammalian codons for snake DNP were cloned downstream of either the leader sequence (referred to as pBDNP-1) or prepropeptide sequence of human brain natriuretic peptide (BNP) cDNA (referred to as pBDNP-2). Transfections with pBDNP-1 or pBDNP-2 resulted in expected forms of chimeric DNP (cDNP) in cell lysates and conditioned media. Functional studies demonstrated the ability of both forms of cDNP within conditioned media to stimulate cGMP production in human vascular smooth muscle cells (hVSMC). Expressed cDNP inhibited hVSMC proliferation and stimulated vasorelaxation in a similar fashion. To investigate the chronic physiological effects of administration of cDNP, an adenoviral vector expressing cDNP (Ad-BDNP) was generated. Intravenous delivery of Ad-BDNP in mice resulted in dose-dependent systemic expression of cDNP. The highest level of expression was associated with consistent elevation of its presumed second messenger (cGMP) for 21 days but with transient lowering of systolic blood pressure in normotensive mice. This study demonstrates the biological features of the expression of the xenogenic peptide DNP.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume286
Issue number6 55-6
DOIs
StatePublished - Jun 2004

Fingerprint

Natriuretic Peptides
Blood Pressure
Genes
Snakes
Conditioned Culture Medium
Vascular Smooth Muscle
Peptides
Smooth Muscle Myocytes
Elapidae
Brain Natriuretic Peptide
Second Messenger Systems
Dendroaspis natriuretic peptide
Vasodilation
Codon
Transfection
Complementary DNA
Cell Proliferation

Keywords

  • Adenoviral
  • Dendroaspis natriuretic peptide
  • Gene delivery

ASJC Scopus subject areas

  • Physiology

Cite this

Gene transfer of a novel vasoactive natriuretic peptide stimulates cGMP and lowers blood pressure in mice. / Pan, Shuchong; Gulati, Rajiv; Mueske, Cheryl S.; Witt, Tyra A.; Lerman, Amir; Burnett, John C Jr.; Simari, Robert D.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 286, No. 6 55-6, 06.2004.

Research output: Contribution to journalArticle

@article{7bf652c2185b417da8c502bb1d1445cb,
title = "Gene transfer of a novel vasoactive natriuretic peptide stimulates cGMP and lowers blood pressure in mice",
abstract = "Dendroaspis natriuretic peptide (DNP) is a recently described peptide produced by Dendroaspis angusticeps with structural and functional similarities to mammalian natriuretic peptides. These similarities suggest a potential role for DNP in cardiovascular therapeutics. To determine the physiological effects of chronic delivery of DNP, a gene transfer approach using first generation adenoviral vectors was utilized. Although the gene for DNP has not been cloned in any species, the peptide sequence in the snake is known. Preferred mammalian codons for snake DNP were cloned downstream of either the leader sequence (referred to as pBDNP-1) or prepropeptide sequence of human brain natriuretic peptide (BNP) cDNA (referred to as pBDNP-2). Transfections with pBDNP-1 or pBDNP-2 resulted in expected forms of chimeric DNP (cDNP) in cell lysates and conditioned media. Functional studies demonstrated the ability of both forms of cDNP within conditioned media to stimulate cGMP production in human vascular smooth muscle cells (hVSMC). Expressed cDNP inhibited hVSMC proliferation and stimulated vasorelaxation in a similar fashion. To investigate the chronic physiological effects of administration of cDNP, an adenoviral vector expressing cDNP (Ad-BDNP) was generated. Intravenous delivery of Ad-BDNP in mice resulted in dose-dependent systemic expression of cDNP. The highest level of expression was associated with consistent elevation of its presumed second messenger (cGMP) for 21 days but with transient lowering of systolic blood pressure in normotensive mice. This study demonstrates the biological features of the expression of the xenogenic peptide DNP.",
keywords = "Adenoviral, Dendroaspis natriuretic peptide, Gene delivery",
author = "Shuchong Pan and Rajiv Gulati and Mueske, {Cheryl S.} and Witt, {Tyra A.} and Amir Lerman and Burnett, {John C Jr.} and Simari, {Robert D.}",
year = "2004",
month = "6",
doi = "10.1152/ajpheart.00465.2003",
language = "English (US)",
volume = "286",
journal = "American Journal of Physiology - Renal Fluid and Electrolyte Physiology",
issn = "1931-857X",
publisher = "American Physiological Society",
number = "6 55-6",

}

TY - JOUR

T1 - Gene transfer of a novel vasoactive natriuretic peptide stimulates cGMP and lowers blood pressure in mice

AU - Pan, Shuchong

AU - Gulati, Rajiv

AU - Mueske, Cheryl S.

AU - Witt, Tyra A.

AU - Lerman, Amir

AU - Burnett, John C Jr.

AU - Simari, Robert D.

PY - 2004/6

Y1 - 2004/6

N2 - Dendroaspis natriuretic peptide (DNP) is a recently described peptide produced by Dendroaspis angusticeps with structural and functional similarities to mammalian natriuretic peptides. These similarities suggest a potential role for DNP in cardiovascular therapeutics. To determine the physiological effects of chronic delivery of DNP, a gene transfer approach using first generation adenoviral vectors was utilized. Although the gene for DNP has not been cloned in any species, the peptide sequence in the snake is known. Preferred mammalian codons for snake DNP were cloned downstream of either the leader sequence (referred to as pBDNP-1) or prepropeptide sequence of human brain natriuretic peptide (BNP) cDNA (referred to as pBDNP-2). Transfections with pBDNP-1 or pBDNP-2 resulted in expected forms of chimeric DNP (cDNP) in cell lysates and conditioned media. Functional studies demonstrated the ability of both forms of cDNP within conditioned media to stimulate cGMP production in human vascular smooth muscle cells (hVSMC). Expressed cDNP inhibited hVSMC proliferation and stimulated vasorelaxation in a similar fashion. To investigate the chronic physiological effects of administration of cDNP, an adenoviral vector expressing cDNP (Ad-BDNP) was generated. Intravenous delivery of Ad-BDNP in mice resulted in dose-dependent systemic expression of cDNP. The highest level of expression was associated with consistent elevation of its presumed second messenger (cGMP) for 21 days but with transient lowering of systolic blood pressure in normotensive mice. This study demonstrates the biological features of the expression of the xenogenic peptide DNP.

AB - Dendroaspis natriuretic peptide (DNP) is a recently described peptide produced by Dendroaspis angusticeps with structural and functional similarities to mammalian natriuretic peptides. These similarities suggest a potential role for DNP in cardiovascular therapeutics. To determine the physiological effects of chronic delivery of DNP, a gene transfer approach using first generation adenoviral vectors was utilized. Although the gene for DNP has not been cloned in any species, the peptide sequence in the snake is known. Preferred mammalian codons for snake DNP were cloned downstream of either the leader sequence (referred to as pBDNP-1) or prepropeptide sequence of human brain natriuretic peptide (BNP) cDNA (referred to as pBDNP-2). Transfections with pBDNP-1 or pBDNP-2 resulted in expected forms of chimeric DNP (cDNP) in cell lysates and conditioned media. Functional studies demonstrated the ability of both forms of cDNP within conditioned media to stimulate cGMP production in human vascular smooth muscle cells (hVSMC). Expressed cDNP inhibited hVSMC proliferation and stimulated vasorelaxation in a similar fashion. To investigate the chronic physiological effects of administration of cDNP, an adenoviral vector expressing cDNP (Ad-BDNP) was generated. Intravenous delivery of Ad-BDNP in mice resulted in dose-dependent systemic expression of cDNP. The highest level of expression was associated with consistent elevation of its presumed second messenger (cGMP) for 21 days but with transient lowering of systolic blood pressure in normotensive mice. This study demonstrates the biological features of the expression of the xenogenic peptide DNP.

KW - Adenoviral

KW - Dendroaspis natriuretic peptide

KW - Gene delivery

UR - http://www.scopus.com/inward/record.url?scp=2542459354&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2542459354&partnerID=8YFLogxK

U2 - 10.1152/ajpheart.00465.2003

DO - 10.1152/ajpheart.00465.2003

M3 - Article

C2 - 14962842

AN - SCOPUS:2542459354

VL - 286

JO - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

JF - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

SN - 1931-857X

IS - 6 55-6

ER -